Topic
dermatology research, explained
1 open-access dermatology studies, each with a flashcard deck and a quiz.
- Why target IL-31 for itch?
This review argues IL-31/IL-31R drive pruritus across skin diseases and highlights nemolizumab as the late-stage antibody against the IL-31 receptor.